[go: up one dir, main page]

DK0500773T3 - Ikke-glycosyleret FGF-4 og præparater indeholdende dette - Google Patents

Ikke-glycosyleret FGF-4 og præparater indeholdende dette

Info

Publication number
DK0500773T3
DK0500773T3 DK91900453T DK91900453T DK0500773T3 DK 0500773 T3 DK0500773 T3 DK 0500773T3 DK 91900453 T DK91900453 T DK 91900453T DK 91900453 T DK91900453 T DK 91900453T DK 0500773 T3 DK0500773 T3 DK 0500773T3
Authority
DK
Denmark
Prior art keywords
preparations containing
glycosylated fgf
fgf
glycosylated
musculo
Prior art date
Application number
DK91900453T
Other languages
English (en)
Inventor
David Thomas Rogers
Neil M Wolfman
Jasbir S Seehra
Original Assignee
Univ New York
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ New York filed Critical Univ New York
Application granted granted Critical
Publication of DK0500773T3 publication Critical patent/DK0500773T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/50—Fibroblast growth factor [FGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK91900453T 1989-11-16 1990-11-15 Ikke-glycosyleret FGF-4 og præparater indeholdende dette DK0500773T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/438,278 US5126323A (en) 1989-11-16 1989-11-16 Homogeneous purified k-fgf and compositions containing the same
PCT/US1990/006702 WO1991007491A1 (en) 1989-11-16 1990-11-15 Non-glycosylated fgf-4 and compositions containing the same

Publications (1)

Publication Number Publication Date
DK0500773T3 true DK0500773T3 (da) 2001-06-18

Family

ID=23739996

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91900453T DK0500773T3 (da) 1989-11-16 1990-11-15 Ikke-glycosyleret FGF-4 og præparater indeholdende dette

Country Status (11)

Country Link
US (2) US5126323A (da)
EP (2) EP0500773B1 (da)
JP (1) JP3020605B2 (da)
AT (1) ATE199167T1 (da)
AU (1) AU642947B2 (da)
CA (1) CA2068871C (da)
DE (1) DE69033703T2 (da)
DK (1) DK0500773T3 (da)
ES (1) ES2156107T3 (da)
GR (1) GR3035682T3 (da)
WO (1) WO1991007491A1 (da)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5459250A (en) * 1987-06-16 1995-10-17 New York University Truncated mammalian growth factor DNA sequence
US5750659A (en) * 1987-06-16 1998-05-12 New York University Mammalian growth factor
US6355781B1 (en) * 1987-06-16 2002-03-12 New York University Mammalian growth factor
US5126323A (en) * 1989-11-16 1992-06-30 Genetics Institute, Inc. Homogeneous purified k-fgf and compositions containing the same
MX9201801A (es) * 1991-04-16 1992-10-30 Seikagaku Kogyo Co Ltd Oligosacarido que tiene afinidad para el factor de desarrollo del fibroplasto y procedimiento para producirlo.
AU4645993A (en) * 1992-06-22 1994-01-24 New York University Mammalian growth factor
US5550114A (en) 1993-04-02 1996-08-27 Thomas Jefferson University Epidermal growth factor inhibitor
US6551618B2 (en) 1994-03-15 2003-04-22 University Of Birmingham Compositions and methods for delivery of agents for neuronal regeneration and survival
US5906827A (en) * 1994-06-03 1999-05-25 Creative Biomolecules, Inc. Matrix for the manufacture of autogenous replacement body parts
US6495518B1 (en) * 1994-06-13 2002-12-17 Vanderbilt University Method for importing biologically active molecules into cells
EP1064382B1 (en) 1998-03-17 2008-08-20 Genentech, Inc. Polypeptides homologous to vegf and bmp1
US6541623B1 (en) 1998-04-03 2003-04-01 Hyseq, Inc. Interleukin—1 receptor antagonist and uses thereof
US6337072B1 (en) 1998-04-03 2002-01-08 Hyseq, Inc. Interleukin-1 receptor antagonist and recombinant production thereof
US6426191B1 (en) 1998-04-03 2002-07-30 Hyseq, Inc. Assays involving an IL-1 receptor antagonist
US6294655B1 (en) 1998-04-03 2001-09-25 Hyseq, Inc. Anti-interleukin-1 receptor antagonist antibodies and uses thereof
US6451303B1 (en) 1998-10-13 2002-09-17 Chiron Corporation Method of treating coronary artery disease by administering a recombinant FGF
US8618052B2 (en) 1998-10-13 2013-12-31 Novartis Vaccines And Diagnostics, Inc. Method of treating coronary artery disease by administering FGF-5
JP4828703B2 (ja) 1999-04-28 2011-11-30 ジェネティックス インスティテュート エルエルシー ヒトｇｉｌ−１９／ａｅ２８９タンパク質、及び、同タンパク質をコードするポリヌクレオチド
EP2067788B1 (en) 1999-05-18 2015-07-22 Dyax Corp. Fab fragment libraries and methods for their use
DK2042597T3 (da) 2000-06-23 2014-08-11 Genentech Inc Sammensætninger og fremgangsmåder til diagnose og behandling af sygdomme, der involverer angiogenese
EP2168980A1 (en) 2000-06-23 2010-03-31 Genentech, Inc. Compositions and methods for the diagnosis and treatment of disorders involving angiogensis
ES2383328T3 (es) 2003-07-25 2012-06-20 Amgen, Inc Métodos relacionados con LDCAM y CRTAM
CN115040636B (zh) * 2021-02-25 2025-06-13 杭州彗搏科技有限公司 多肽在促进软骨再生或修复中的用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4956455A (en) * 1984-03-05 1990-09-11 The Salk Institute For Biological Studies Bovine fibroblast growth factor
US4785079A (en) * 1984-11-09 1988-11-15 The Salk Institute For Biological Studies Isolation of fibroblast growth factor
ATE222602T1 (de) * 1985-09-12 2002-09-15 Scios Inc Rekombinante fibroblasten-wachstums-faktoren
IL81839A0 (en) * 1986-03-14 1987-10-20 Takeda Chemical Industries Ltd Polypeptide,dna and its use
NZ220917A (en) * 1986-07-11 1991-05-28 Merck & Co Inc Human and bovine acidic fibroblast growth factor vectors, hosts and compositions
FI884252A7 (fi) * 1987-01-16 1988-09-15 Amgen Inc Menetelmä fibroblasti-kasvu-tekijän valmistamiseksi.
NZ226543A (en) * 1987-10-22 1992-02-25 Merck & Co Inc Recombinant mutant acidic fibroblast growth factor
AU624803B2 (en) * 1988-01-25 1992-06-25 American Cyanamid Company Heparin - binding brain mitogens
US5126323A (en) * 1989-11-16 1992-06-30 Genetics Institute, Inc. Homogeneous purified k-fgf and compositions containing the same

Also Published As

Publication number Publication date
CA2068871A1 (en) 1991-05-17
JPH05503090A (ja) 1993-05-27
JP3020605B2 (ja) 2000-03-15
CA2068871C (en) 2003-02-11
DE69033703T2 (de) 2001-09-13
US5430019A (en) 1995-07-04
EP0500773B1 (en) 2001-02-14
US5126323A (en) 1992-06-30
DE69033703D1 (de) 2001-03-22
WO1991007491A1 (en) 1991-05-30
AU6894291A (en) 1991-06-13
AU642947B2 (en) 1993-11-04
EP0500773A1 (en) 1992-09-02
GR3035682T3 (en) 2001-06-29
EP0835932A1 (en) 1998-04-15
ES2156107T3 (es) 2001-06-16
ATE199167T1 (de) 2001-02-15

Similar Documents

Publication Publication Date Title
DK0500773T3 (da) Ikke-glycosyleret FGF-4 og præparater indeholdende dette
EP0335901A4 (en) Methods and compositions for the treatment of non-ige-mediated diseases
DK0396404T3 (da) Farmaceutisk middel indeholdende loratadin, ibuprofen og pseudoephedrin
BR9814857A (pt) Processos para tratar leucemia, câncer sólido eleucemia, linfoma ou tumores sólidos em umhumano, e para fabricar uma composiçãofarmacêutica estéril, e, a respectiva composiçãofarmacêutica estéril
NZ226005A (en) Covalent conjugates of a human cytokine and a human immunoglobulin, processes for their manufacture and pharmaceutical compositions thereof
TW221056B (da)
ZA87884B (en) Therapeutic agent
EP0296573A3 (en) Novel nucleosides, their preparation and pharmaceutical novel nucleosides, their preparation and pharmaceutical compositions compositions
PT88275A (pt) Processo para a preparacao de composicoes farmaceuticas contendo 5-amino ou amino substituido-1,2,3-triazois uteis como agentes antiproliferativos
GR3006815T3 (da)
KR0156686B1 (en) Pharmaceutical composition comprising aryl-substituted rhodanine derivatives
EP0553294A4 (en) Methods and compositions for the treatment of cell proliferation disorders
ATE114974T1 (de) Abgabe von cytotoxischen mitteln.
IT1240683B (it) Composizione farmaceutica contenente egf
ZA878249B (en) Method and therapeutic compositions for the treatment of bleeding disorders
ES2066096T3 (es) 4-bencil-5-fenil-2,4-dihidro-3h-1,2,4-triazol-3-onas y su uso como anticonvulsivos.
EP0588477A3 (en) Medicinal composition comprising tcf-ii
EP0544802A4 (en) Methods and compositions for treating t-cell mediated diseases
ZA893310B (en) Novel strobilurine derivatives,their preparation and their use
KR950701347A (ko) 신규한 향종양성 사이토킨(A novel anti-neoplastic cytokine)
DK0486586T3 (da) Kynurensyrederivater, fremstilling deraf og farmaceutiske præparater, der indeholder dem
EP0301449A3 (en) Enantiomers of propafenone-containing therapeutic agents
SE8802323D0 (sv) 8alfa-acylaminoergoline, its preparation and pharmaceutical compositions containing it
DK0608648T3 (da) Højdoserede vitamin A-præparater
IT9041714A0 (it) Linfa del libro dell'abete rosso (abies picea) per la cura di malattie neoplastiche e da virus in genere